Kodiak Sciences Inc. (KOD)
Kodiak Sciences Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to discovering, advancing, and bringing to market treatments for various conditions affecting the retina. Their primary drug candidate, KSI-301, is an anti-vascular endothelial growth factor (anti-VEGF) antibody biopolymer. This compound is currently undergoing Phase IIb/III clinical trials, targeting illnesses such as wet age-related macular degeneration (AMD), diabetic macular edema, previously untreated macular edema resulting from retinal vein occlusion, and non-proliferative diabetic retinopathy. In its earlier, preclinical development pipeline, the company is also working on KSI-501, a bispecific conjugate designed for retinal conditions involving inflammation, and KSI-601, a triplet inhibitor aimed at addressing dry AMD. Established in 2009, this Palo Alto, California-based company operated under the name Oligasis, LLC before rebranding as Kodiak Sciences Inc. in September 2015.
Sector: Biological Products, (No Diagnostic Substances)
Industry: Biotechnology
Kodiak Sciences Inc.
NASDAQ:KODHealthcare · Biotechnology
-1.22%$99.18
AH$99.99+0.82%vs close
Mkt Cap$6.23B
Float29.6M
O/S62.85M
Vol
$ Vol
RVOL
Inst Own96.4%
SI28.7%
Earnings
Dilution
Financials Summary
Revenue$0
Net Income-$229.97M
Total Assets$351.53M
Free Cash Flow-$136.51M
Debt & Equity
Debt 50%
Equity 50%
Total Debt$159.18M
Total Equity$157.38M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in KOD's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$351.53M
Liabilities$194.15M
Accounts Receivable$0
Accounts Payable$12.86M
Inventory$0
PP&E (Net)$121.86M
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | - | - | - | - | - | - | - | - | - | - |
| Cost of Revenue | $0 | $26.71M | $25.95M | $11M | $8.71M | $4.21M | $911K | $490K | $549K | $257K |
| Gross Profit | $0 | -$26.71M | -$25.95M | -$11M | -$8.71M | -$4.21M | -$911K | -$490K | -$549K | -$257K |
| Gross Margin | - | - | - | - | - | - | - | - | - | - |
| Research and Development | $182.37M | $126.09M | $206.3M | $267.59M | $217.34M | $107.39M | $37.51M | $18.79M | $22.02M | $14.05M |
| Selling, General, and Administrative | $52.02M | $34.05M | $71.02M | $62.79M | $41M | $24.41M | $10.77M | $7.58M | $3.5M | $3.1M |
| Other | $0 | $0 | -$25.95M | $0 | $0 | $0 | $0 | -$4.07M | -$1.23M | $25K |
| Total Operating Expenses | $234.39M | $160.14M | $251.37M | $330.38M | $258.34M | $131.8M | $48.28M | $26.37M | $25.52M | $17.15M |
| Operating Income (EBIT) | -$234.39M | -$186.85M | -$277.32M | -$341.38M | -$267.05M | -$136.01M | -$49.19M | -$26.37M | -$25.52M | -$17.15M |
| Operating Margin | - | - | - | - | - | - | - | - | - | - |
| Interest Expense | $0 | $0 | $13K | $18K | $22K | $25K | $8K | $5.52M | $1.19M | $6K |
| Interest Income | $4.52M | $11.15M | $16.73M | $7.07M | $298K | $2.9M | $1.57M | $0 | $0 | $0 |
| Other Income (Expense) | $4.42M | $10.64M | $16.83M | $7.56M | $61K | $2.91M | $1.82M | -$15.07M | -$2.42M | $19K |
| Income Before Tax (EBT) | -$229.97M | -$176.21M | -$260.49M | -$333.82M | -$266.99M | -$133.1M | -$47.37M | -$41.44M | -$27.94M | -$17.13M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$45K | $31K |
| Net Income | -$229.97M | -$176.21M | -$260.49M | -$333.82M | -$266.99M | -$133.1M | -$47.37M | -$41.44M | -$27.94M | -$17.13M |
| Net Income Margin | - | - | - | - | - | - | - | - | - | - |
| Supplementary Data | ||||||||||
| EPS | -4.32 | -3.35 | -4.97 | -6.39 | -5.16 | -2.91 | -1.23 | -1.16 | -1.05 | -2.30 |
| Diluted EPS | -4.32 | -3.35 | -4.97 | -6.39 | -5.16 | -2.91 | -1.23 | -1.16 | -1.05 | -2.30 |
| Weighted Average OS | 53.21M | 52.58M | 52.41M | 52.25M | 51.79M | 45.74M | 37.85M | 35.87M | 26.56M | 7.44M |
| EBITDA | -$203.65M | -$149.5M | -$234.53M | -$322.8M | -$258.26M | -$128.86M | -$46.45M | -$35.43M | -$26.2M | -$16.87M |
| EBITDA Margin | - | - | - | - | - | - | - | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
| Assets | ||||||||||
| Current Assets | ||||||||||
| Cash and Cash Equivalents | $209.86M | $168.07M | $285.51M | $190.43M | $731.51M | $944.4M | $211.8M | $88.25M | $1.4M | $9.62M |
| Short-Term Investments | $0 | $0 | $0 | $288.5M | $0 | $24.58M | $124.68M | $0 | $0 | $0 |
| Cash and Short-Term Investments | $209.86M | $168.07M | $285.51M | $478.93M | $731.51M | $968.97M | $336.48M | $88.25M | $1.4M | $9.62M |
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $4.95M | $3.86M | $3.8M | $7.07M | $3.3M | $0 | $2.75M | $2.19M | $0 | $0 |
| Total Current Assets | $214.82M | $171.94M | $289.31M | $486M | $734.81M | $972M | $339.23M | $90.45M | $1.59M | $10.19M |
| Long-Term Assets | ||||||||||
| Property, Plant & Equipment Net | $121.86M | $148.73M | $175.02M | $115.75M | $108.07M | $78.81M | $2.79M | $1.1M | $1.51M | $1.78M |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $6.18M | $6.18M | $6.32M | $6.32M | $6.32M | $0 | $11.84M | $140K | $140K | $140K |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $8.67M | $8.73M | $8.72M | $58.55M | $55.01M | $16.53M | $5.01M | $503K | $0 | $8K |
| Total Long-Term Assets | $136.72M | $163.64M | $190.06M | $180.62M | $169.41M | $95.34M | $19.64M | $1.74M | $1.65M | $1.92M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $351.53M | $335.58M | $479.37M | $666.63M | $904.22M | $1.07B | $358.87M | $92.19M | $3.24M | $12.11M |
| Liabilities | ||||||||||
| Current Liabilities | ||||||||||
| Accounts Payable | $12.86M | $3.92M | $13.61M | $9.13M | $12.43M | $8.65M | $2.62M | $1.05M | $3.36M | $1.07M |
| Short-Term Debt | $12.06M | $0 | $9.77M | $9.93M | $3.93M | $0 | $434K | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $12.84M | $0 | $12.27M | $27.41M | $42.13M | $0 | $5.55M | $0 | -$108K | $84K |
| Total Current Liabilities | $45.53M | $25.57M | $41.73M | $52.5M | $64.68M | $31.42M | $11.71M | $4.83M | $9.16M | $2.51M |
| Long-Term Liabilities | ||||||||||
| Long-Term Debt | $100M | $0 | $100M | $100M | $99.94M | $0 | $0 | $0 | $9.97M | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $1.5M | $100M | $0 | $162K | $211K | $100.15M | $295K | $530K | $52.85M | $50.59M |
| Total Long-Term Liabilities | $148.62M | $159.72M | $171.86M | $177.97M | $176.22M | $175.17M | $1.8M | $530K | $62.82M | $50.69M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $194.15M | $185.29M | $213.59M | $230.46M | $240.9M | $206.6M | $13.51M | $5.36M | $71.98M | $53.2M |
| Stockholders' Equity | ||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $6K | $5K | $5K | $5K | $5K | $5K | $5K | $4K | $1K | $1K |
| Retained Earnings | -$1.56B | -$1.33B | -$1.15B | -$892.04M | -$558.22M | -$291.23M | -$158.13M | -$110.77M | -$69.32M | -$41.39M |
| Comprehensive Income & Other | $0 | $0 | $0 | -$1.31M | $0 | $53K | $10K | $0 | $0 | $0 |
| Other Stockholders' Equity | $1.72B | $1.48B | $1.42B | $1.33B | $1.22B | $1.15B | $503.49M | $197.59M | $584K | $303K |
| Total Equity | $157.38M | $150.29M | $265.78M | $436.17M | $663.32M | $860.75M | $345.36M | $86.83M | -$68.74M | -$41.08M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $351.53M | $335.58M | $479.37M | $666.63M | $904.22M | $1.07B | $358.87M | $92.19M | $3.24M | $12.11M |
| Supplementary Data | ||||||||||
| Total Debt | $159.18M | $70.34M | $181.63M | $187.73M | $179.94M | $77.4M | $1.94M | $0 | $10.08M | $185K |
| Net Debt | -$50.68M | -$97.73M | -$103.88M | -$2.7M | -$551.57M | -$866.99M | -$209.86M | -$88.25M | $8.69M | -$9.44M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
| Operating Activities | ||||||||||
| Net Income | -$229.97M | -$176.21M | -$260.49M | -$333.82M | -$266.99M | -$133.1M | -$47.37M | -$41.44M | -$27.94M | -$17.13M |
| Depreciation & Amortization | $26.32M | $26.71M | $25.95M | $11M | $8.71M | $4.21M | $911K | $490K | $549K | $257K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | -$51K | $0 | $10.17M | $1.26M | $0 |
| Stock-Based Compensation | $58.86M | $60.21M | $88.56M | $106.03M | $61.38M | $30.67M | $6.11M | $2.67M | $275K | $272K |
| Changes in Working Capital: | ||||||||||
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | $8.07M | -$9.69M | $5.6M | $1.66M | -$2.09M | $5.22M | $1.57M | -$2.32M | $2.28M | $23K |
| Other Working Capital | -$1.22M | -$18.69M | -$12.95M | $10.3M | $16.52M | $9.57M | -$130K | -$4.07M | $4.75M | $533K |
| Total Working Capital Change | $6.85M | -$28.39M | -$7.36M | $11.96M | $14.43M | $14.79M | $1.44M | -$6.39M | $7.04M | $556K |
| Other Non-Cash Items | $1.93M | $355K | -$840K | -$1.63M | $198K | $49K | -$241K | $5.48M | $1.16M | $763K |
| Net Cash from Operating | -$136.01M | -$117.32M | -$154.18M | -$206.46M | -$182.27M | -$83.43M | -$39.15M | -$29.03M | -$17.66M | -$16.05M |
| Investing Activities | ||||||||||
| Capital Expenditures | -$506K | -$400K | -$41.43M | -$47.36M | -$63.3M | -$7M | -$437K | -$581K | -$209K | -$771K |
| Acquisitions | $0 | $0 | -$291K | $0 | $0 | $3.18M | $137K | $0 | $0 | $0 |
| Purchases of Investments | $0 | -$355K | -$49.35M | -$427.77M | $0 | -$86.32M | -$150.96M | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $340M | $138M | $24.5M | $198.15M | $14.4M | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $291K | $616K | $0 | -$3.18M | -$137K | -$503K | $0 | $0 |
| Net Cash from Investing | -$506K | -$755K | $249.23M | -$336.51M | -$38.8M | $104.83M | -$137M | -$581K | -$209K | -$771K |
| Financing Activities | ||||||||||
| Debt Repaid | - | - | - | - | - | $5K | $48K | -$32.89M | -$9.9M | $62K |
| Common Stock Issuance | $178.3M | $501K | $242K | $1.94M | $8.23M | $612.02M | $297.62M | $83.75M | $3K | $1K |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | -$487K | -$132K | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $0 | -$211K | -$49K | -$45K | $105.85M | $2.25M | -$176K | -$266K | -$58K |
| Net Cash from Financing | $178.3M | $501K | $31K | $1.9M | $8.18M | $717.38M | $299.69M | $116.47M | $9.64M | -$120K |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $41.79M | -$117.57M | $95.07M | -$541.08M | -$212.89M | $738.78M | $123.54M | $86.86M | -$8.23M | -$16.94M |
| Supplementary Data | ||||||||||
| Operating Cash Flow | -$136.01M | -$117.32M | -$154.18M | -$206.46M | -$182.27M | -$83.43M | -$39.15M | -$29.03M | -$17.66M | -$16.05M |
| Capital Expenditure | -$506K | -$400K | -$41.43M | -$47.36M | -$63.3M | -$7M | -$437K | -$581K | -$209K | -$771K |
| Free Cash Flow | -$136.51M | -$117.72M | -$195.61M | -$253.82M | -$245.57M | -$90.43M | -$39.58M | -$29.61M | -$17.86M | -$16.82M |
| Cash at Beginning | $174.26M | $291.83M | $190.43M | $731.51M | $950.72M | $211.94M | $88.39M | $1.53M | $9.76M | $26.7M |
| Cash at End | $216.05M | $174.26M | $285.51M | $190.43M | $737.83M | $950.72M | $211.94M | $88.39M | $1.53M | $9.76M |